JAMES R WOODS, MD
Medical Practice at Elmwood Ave, Rochester, NY
License number
New York 166087
Category
Medical Practice
Type
Maternal & Fetal Medicine
Address
Address
601 Elmwood Ave, Rochester, NY 14642
Phone
(585) 271-7800
(585) 256-1416 (Fax)
(585) 275-0638
(585) 273-3359 (Fax)
(585) 256-1416 (Fax)
(585) 275-0638
(585) 273-3359 (Fax)
Personal information
See more information about JAMES R WOODS at radaris.comName
Address
Phone
4667 Porter Center Rd, Lewiston, NY 14092
4616 Chapman Pkwy, Hamburg, NY 14075
457 Centre St #103, Cape Vincent, NY 13618
45 Mayfair Ave, Floral Park, NY 11001
Organization information
See more information about JAMES R WOODS at bizstanding.comStrong Perinatal Group - James R Woods MD
500 Red Crk Dr STE 210, Rochester, NY 14623
Categories:
Physicians & Surgeons
Site:
Phone:
(585) 487-3350 (Phone)
Products:
Strong Health
Additional:
For Everything You Go Through in Life, We're Here, The New Women's Health Pavilion, the Only Center of Its Kind in the Region., University of Rochester, Medical Center
James R Woods MD
601 Elmwood Ave #668, Rochester, NY 14642
Categories:
Gynecology & Obstetrics Physicians & Surgeons
Phone:
(585) 275-5201 (Phone)
Professional information
Dr. James R Woods, Rochester NY - MD (Doctor of Medicine)
Specialties:
Gynecology
Address:
UNIVERSITY OF ROCHESTER
2255 Clinton Ave S, Rochester 14618
(585) 271-7800 (Phone), (585) 473-6911 (Fax)
2255 Clinton Ave S, Rochester 14618
(585) 271-7800 (Phone), (585) 473-6911 (Fax)
Procedures:
Ultrasound-Female Pelvis
Conditions:
Menopause
Certifications:
Fetal Medicine & Maternal Medicine, Obstetrics & Gynecology
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF ROCHESTER
2255 Clinton Ave S, Rochester 14618
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
2255 Clinton Ave S, Rochester 14618
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Philosophy:
Menopause is a critical chapter in a women?s life. We as careproviders must be able to teacher the biology of menopause, be a good listener, and be effective with managing urinary incontinence, mood swings, memory loss, hot flashes, bone health, skin changes, and cardiac health. Serving in that role we can advance the importance of diet, exercise, sleep, weight loss, role of alternative medicines, and hormonal management.
Education:
Medical School
Wake Forest University School Of Medicine, Medical Center Boulevard
Graduated: 1970
Tripler Amc
Graduated: 1971
UCLA Med Center
Graduated: 1976
Allegeny College Meadville, Pa
Graduated: 1966
Wake Forest University School Of Medicine, Medical Center Boulevard
Graduated: 1970
Tripler Amc
Graduated: 1971
UCLA Med Center
Graduated: 1976
Allegeny College Meadville, Pa
Graduated: 1966
James R Woods, Rochester NY
Specialties:
Obstetrics & Gynecology, Maternal & Fetal Medicine, Gynecology, Obstetrics
Work:
Strong Memorial Hospital
601 Elmwood Ave, Rochester, NY 14642
601 Elmwood Ave, Rochester, NY 14642
Education:
Wake Forest University (1970)
Chairman Ob/Gyn At U Or R
Position:
chairman ob/gyn at U or R
Location:
Rochester, New York Area
Industry:
Medical Practice
Work:
U or R
since Jul 2002
-
chairman ob/gyn
Method For Determination Of Likelihood Of Occurrence Of Preterm Labor In Pregnant Females
US Patent:
2006016, Jul 27, 2006
Filed:
Jun 30, 2003
Appl. No.:
10/519884
Inventors:
James Woods - Rochester NY, US
Marion Andres - Rochester NY, US
Lin Xu - Rochester NY, US
Marion Andres - Rochester NY, US
Lin Xu - Rochester NY, US
International Classification:
G01N 33/537
US Classification:
435007920
Abstract:
The presence of 3-chlorotyrosine in vaginal secretions in a predictor of the likelihood preterm premature rupture of the fetal membranes, i.e., the chorioamnion and/or the occurrence of the risk of preterm labor. 3-chlorotyrosine is a marker for the excessive production of hypochlorous acid which causes focal areas of increased collagen destruction in the chorioamnion, preterm premature rupture of membranes, or increased production of postaglandin and preterm labor. The inventive method comprises determining the likelihood of the occurrence of preterm premature rupture of membranes or increased production of postaglandin and preterm labor in a pregnant female by obtaining a sample of the females vaginal secretions, and analyzing the secretions for the presence and amount of 3-chlorotyrosine in the sample. Various antibody-based tests can be used to measure 3-chlorotyrosine, and a number of neoantigens, useful in raising antibodies to 3-chlorotyrosine, are disclosed.